DEF: Inspire Veterinary Faces Going Concern Warning

Inspire Veterinary Partners, Inc. disclosed a 'going concern' warning from its former auditor and material weaknesses in internal controls, alongside routine annual meeting proposals.

Summary

• The 2025 Annual Meeting of Stockholders will be held virtually on Wednesday, December 10, 2025, at 10 a.m. Eastern Time.
• Key proposals for the Annual Meeting include the election of seven directors and the ratification of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Board of Directors unanimously recommends voting FOR the election of each director nominee and FOR the ratification of M&K CPAS, PLLC.
• The record date for stockholders entitled to vote at the Annual Meeting was October 14, 2025.
• As of October 14, 2025, there were 3,647,610 shares of Class A common stock outstanding (one vote per share) and 3,020,750 shares of Class B common stock outstanding (twenty-five votes per share), totaling 79,166,360 votes.
• A quorum for the Annual Meeting requires the presence, in person or by proxy, of holders representing at least 33 1/3% (26,441,565 votes) of the total votes entitled to be cast.
• The Company dismissed Kreit & Chiu CPA LLP (K&C) as its independent registered public accounting firm on October 16, 2025, and appointed M&K CPAS, PLLC.
• K&C's audit reports for the fiscal years ended December 31, 2024, and 2023, included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
• K&C also advised the Company of material weaknesses in its internal control over financial reporting during the two most recent fiscal years and the subsequent interim period through October 16, 2025.
• No bonuses were paid to the Chief Executive Officer, Kimball Carr, or the Chief Financial Officer, Richard Frank, in 2024, despite their eligibility for annual revenue and profit-based bonuses.

Sentiment

Score: 3

Explanation: The filing reveals critical financial health issues, including a 'going concern' warning from the former auditor and identified material weaknesses in internal controls. While it addresses routine governance matters like director elections and auditor ratification, these underlying financial and operational concerns overshadow any procedural positives. Related party transactions also present potential governance risks.

Positives

• The Board of Directors is composed of a majority of independent directors, with seven out of eight members (excluding the CEO and Charles Stith Keiser) meeting independence requirements.
• All three standing committees (Audit, Compensation, and Governance and Nominating) are comprised solely of independent directors, enhancing oversight.
• The Company has adopted a Code of Business Conduct and Ethics and an executive incentive compensation recovery policy (clawback policy), aligning with good corporate governance practices.
• The executive team possesses extensive experience in the veterinary services industry, finance, human resources, and operations, which is crucial for the Company's core business.

Negatives

• The former independent auditor issued a 'going concern' opinion for fiscal years 2023 and 2024, indicating significant financial uncertainty and potential inability to meet obligations.
• Material weaknesses in internal control over financial reporting were identified by the former auditor, raising concerns about the reliability of financial statements and risk of misstatement.
• No annual bonuses were paid to the CEO or CFO in 2024, suggesting that the Company did not meet its revenue and profit targets for the year.
• The Company has not adopted a policy prohibiting directors, officers, and employees from engaging in hedging or pledging company stock, which could lead to misaligned incentives.
• Several related party transactions, including loans from a director and his father, and consulting agreements with entities partially owned by the CEO and a director, raise potential conflict of interest concerns.

Risks

• Substantial doubt about the Company's ability to continue as a going concern, as explicitly stated by the former independent registered public accounting firm.
• Material weaknesses in internal control over financial reporting, which could lead to errors in financial statements, fraud, or non-compliance with regulatory requirements.
• Potential conflicts of interest arising from transactions with related parties, including loans and consulting agreements involving directors and executive officers.
• Lack of a policy prohibiting hedging or pledging company stock by insiders, which could expose the Company to reputational risk or create incentives misaligned with long-term shareholder value.
• Reliance on key management personnel, as detailed in their employment agreements, where their departure could significantly impact operations.

Future Outlook

The filing primarily focuses on corporate governance and the upcoming annual meeting, providing limited explicit forward-looking financial guidance or strategic outlook. The 'going concern' warning from the former auditor, however, implies a challenging financial outlook and significant uncertainty regarding the Company's long-term viability.

Management Comments

• "Your vote is important. Please take the time to vote as promptly as possible." Kimball Carr, Chair of the Board, President and Chief Executive Officer.
• The Board believes it is important to retain its flexibility to allocate the responsibilities of the offices of the Chair of the Board and the Chief Executive Officer in a way that is in the best interest of the Company at any given point in time.
• The Board believes that combining the Chief Executive Officer and Chair of the Board positions is the right corporate governance structure for the Company at this time because it most effectively uses Mr. Carr's experience and knowledge of the Company, places him in the best position to focus the independent directors' attention on the issues of greatest importance to the Company and its stockholders, and provides the Company with unified leadership.

Industry Context

The Company operates in the veterinary services industry, a sector generally characterized by stable demand and growth driven by increasing pet ownership and the humanization of pets. The executive team's biographies highlight extensive experience within this industry, including roles at major veterinary organizations and consulting firms. However, the Company's specific financial challenges, including the 'going concern' warning and internal control weaknesses, appear to be company-specific rather than indicative of broader industry trends.

Comparison to Industry Standards

• The 'going concern' explanatory paragraph in the auditor's reports for two consecutive fiscal years (2023 and 2024) is a significant deviation from industry standards for financially healthy publicly traded companies.
• The identification of material weaknesses in internal control over financial reporting is below the expected standard for public companies, which are required to maintain effective internal controls to ensure reliable financial reporting.
• The presence of multiple related party transactions, while not uncommon, warrants close scrutiny and could be viewed as a governance weakness compared to companies with more stringent related party transaction policies.

Management Changes

Corporate Governance

Legal Proceedings

• No directors or executive officers have been involved in any legal proceedings in the past ten years relating to bankruptcy, insolvency, or criminal proceedings (other than minor traffic offenses).

Related Party Transactions

• **Keiser Loans**: On August 10, 2022, Charles Stith Keiser (director, former COO, largest shareholder) and his father advanced $150,000 each, totaling $300,000, to the Company for working capital. These interest-free advances included a $5,000 fee to each lender and were repaid prior to the Company's IPO on August 31, 2023.
• **Blue Heron Consulting (BHC) Agreement**: The Company received acquisition, business, and financial advisory services from BHC, where Charles Stith Keiser is the Chief Operating Officer and his father is the Chief Visionary Officer. The Company paid approximately $1.1 million to BHC during the agreement's term (terminated Q4 2023) and $83,168 in 2024 for ad hoc services.
• **Star Circle Advisory Group, LLC Agreement**: The Company entered a consulting agreement with Star Circle on August 2, 2022, for financial consulting and IPO assistance. Star Circle is partially owned and controlled by Kimball Carr (CEO). The agreement, which included a $33,000 monthly fee, was terminated in Q4 2023, with the Company incurring $284,900 in expenses for 2023.
• **Chief Executive Officer's Warrant**: On January 1, 2023, Kimball Carr (CEO) received a warrant to purchase up to 20 shares of Class A common stock at $6,000 per share, valued at $2,701 at issuance, in consideration for his personal guaranty of Company loans.
• **Sale of Kauai Veterinary Clinic**: On September 20, 2024, the Company sold Kauai Veterinary Clinic to Kauai RE Holdings LLC, an entity where the father of board member Charles Stith Keiser is a member. The consideration for the sale was Kauai RE Holdings LLC assuming $2 million in debt.

Stakeholder Impact

• **Shareholders**: Face significant risk due to the 'going concern' warning and material weaknesses in internal controls, which could negatively impact share price and investment value. The election of directors and auditor ratification are key governance decisions.
• **Employees**: The Company's financial instability, as indicated by the 'going concern' warning, could raise concerns about job security and future growth opportunities.
• **Creditors**: The 'going concern' warning is highly relevant to creditors, as it signals potential difficulties for the Company to meet its financial obligations in the future.
• **Management**: Executive compensation, including the absence of bonuses in 2024, reflects the Company's performance challenges. The detailed employment agreements outline their roles and severance terms.

Next Steps

• Stockholders are encouraged to vote on the election of seven directors and the ratification of M&K CPAS, PLLC as the independent registered public accounting firm by December 9, 2025 (internet voting deadline) or at the virtual Annual Meeting on December 10, 2025.
• The Board will consider its options if the appointment of M&K CPAS, PLLC is not ratified by stockholders.
• Final voting results from the Annual Meeting will be published in a Current Report on Form 8-K within four business days after the meeting.
• Stockholders wishing to submit proposals for the 2026 proxy statement must do so by June 26, 2026.
• Stockholders wishing to bring proposals or nominate directors for the 2026 annual meeting must provide notice between August 12, 2026, and September 11, 2026.

Key Dates

Recommendation

The filing contains critical red flags for investors, most notably the 'going concern' explanatory paragraph in the former auditor's reports for both 2023 and 2024, and identified material weaknesses in internal controls. These indicate severe financial instability and potential risks to the company's operational viability and financial reporting integrity. The presence of multiple related-party transactions, including loans and consulting agreements with entities tied to management and directors, further raises governance concerns and potential conflicts of interest. While the company is addressing routine governance matters, the fundamental financial health issues suggest a high-risk investment profile. The lack of bonuses for top executives in 2024, despite performance targets, also points to underperformance. Given these significant risks and uncertainties, a seasoned investor would likely recommend selling the stock.

Keywords

Veterinary services, Corporate governance, SEC filing, Proxy statement, Going concern, Internal controls, Auditor change, Director election, Related party transactions, Executive compensation, Stockholder meeting, Financial reporting